Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Gardens and art represent public spaces and support venues of interactions and emotions, seeking not only a variety of conversational themes but also various cognitive skills such as mnemonic skills. The cognitive and psycho-behavioral effects of art and the garden, jointly associated and made available to patients suffering from Alzheimer's disease, need to be evaluated.
MAIN OBJECTIVE Delineate the psychological scaffolding virtues of art and garden on cognitive and emotional processes by means of interview analyses in Alzheimer patients and control subjects based on the " art, memory and life " garden.
SECONDARY OBJECTIVES Adapt eco-psychosocial approaches of care management to Alzheimer patients:
SECONDARY ENDPOINTS
RESEARCH METHODOLOGY
Open, monocentric, controlled (group of healthy control subjects) study.
Population: 2 groups:
Group A "Alzheimer group": patients with mild to severe stages of Alzheimer's disease: subgroup A1 "Alzheimer group hospitalized at the Paul Spillmann Centre (Centre Paul Spillmann, CPS)" (CHU de Nancy, France); subgroup A2 "Alzheimer group monitored at the Resource and Research Memory Centre (Centre Mémoire de Ressources et de Recherche, CMRR)" (CHU de Nancy, France) Group B "healthy control group": healthy volunteers
Therapeutic fallouts of this study will benefit Alzheimer patients in terms of better care management, notably: i) by determining the design, conception and layout of the gardens destined to these patients, ii) by developing the introduction of an artistic dimension to the design of such healing gardens and in their living environment, iii) by establishing workshop application perspectives using the contemplation of works of art and the garden for therapeutic purposes.
RESEARCH METHODOLOGY / EXPERIMENTAL DESIGN
Open, monocentric, controlled (group of healthy control subjects) study.
Population: 2 groups:
Group A "Alzheimer group": patients with mild to severe stages of Alzheimer's disease: subgroup A1 "Alzheimer group hospitalized at the Paul Spillmann Centre (Centre Paul Spillmann, CPS)" (CHU de Nancy, France); subgroup A2 "Alzheimer group monitored at the Resource and Research Memory Centre (Centre Mémoire de Ressources et de Recherche, CMRR)" (CHU de Nancy, France) Group B "healthy control group": healthy volunteers
SPECIFIC ASSESSMENT PROCEDURES
TASKS SPECIFIC TO THE STUDY: MATERIALS
Interview methodology: The interrelationships between garden, art, cognition and behavior will be assessed. The endpoints of these dimensions will be achieved by an analysis of subject-psychologist interactions via interviews in the garden (in-context) and in out-of-context mnemonic interviews. These interviews will be recorded and transcribed verbatim. The interest of juxtaposing these two interview situations, in a comparative analysis of interactional production, is to be able to access different cognitive skills in order to analyze these skills. All of the data will be extracted through the quantitative analysis of discursive productions stemming from Interlocutory Logic (Trognon and Batt, 2007, 2010, 2011). The investigators analyses will consist, on the one hand, of exploring the public production of private thoughts of the subject (cognition and emotions) and secondly, to modelize interactive behaviors. The interlocutory space will be both referential and modal. All in all, the investigators will observe and analyze the eventual discursive productions of the subject in reference to the "art, memory and life" garden, whether they are related to the subject's experiences in the garden (in-context), to the narrative situation in recounting his or her experience in the garden (out-of-context) or to the spontaneous use of the garden for subjects in group A1. The implemented approach will have a strong ecological perspective.
Interlocutory logic is an analysis method developed in the INTERPSY laboratory . This pragmatic-dialogic method analyzes discourse in situations of interaction. This analytical process is aimed at expliciting the basic components of communication, interlocutory management and socio-cognitive-discursive events occurring in conversations.
For subjects in Group A:
Mood assessment: Cornell Scale for Depression in Dementia (CSDD, Cornell, 1988), translated into French.
For subjects in Group A and in Group B
Interview-discovery and interview-knowledge of the garden (in-context) (30 min per interview): During the walk-through, the subject, accompanied by the psychologist, will observe the entire garden and its artistic elements. The subject will be queried through a discussion aimed at promoting the expressing of immediate reactions on the artistic dimensions. The analytical approach will enable to assess:
Out-of-context assessments (90 min per assessment):
ASSESSMENT SCHEDULE SPECIFIC TO THE RESEARCH
Group A " Alzheimer Group "
Subgroup A1 " Alzheimer group hospitalized at the Paul Spillmann Centre "
Inclusion visit With the investigator/physician
With the psychologist: T0:
Visit 1 (as soon as possible after the inclusion visit)
Takes place in 2 stages on the same day:
Spontaneous use of the garden
Visit 2 (after a three-day period of spontaneous use of the garden, consecutive or not, or from the 4th day onward within a maximum delay of 10 days after visit 1)
Subgroup A2 "Alzheimer group monitored at the Resource and Research Memory Centre (CMRR) "
At the CMRR with the investigator/physician:
Visit 1 (over a single day, at the CPS)
Inclusion work-up with the investigator/physician of the CPS:
With the psychologist:
- T0: CSDD and AES scales ACA questionnaire GEP assessment
Visit 2 (without use of the garden) within a maximum delay of 10 days after visit 1
Group B: " healthy control group "
Visit 1 (over a single day, at the CPS)
With the investigator/physician: inclusion work-up:
With the psychologist:
-T0: Neuropsychological assessment (90 min): neuropsychological tests used in routine clinical practice CSDD and AES scale ACA questionnaire GEP assessment
Visit 2 (without use of the garden) within a maximum delay of 10 days after visit 1
DURATION OF THE STUDY Duration of inclusion period: 3 years Duration of participation: maximum 8 weeks for the patients (including the follow-up period); 11 days for control subjects Total duration time: 38 months (including analysis period and presentation of data)
STATISTICAL ANALYSIS The descriptive analysis will be performed by computing frequencies for categorical variables and mean and standard deviation or median and extreme values for continuous variables. The analysis will include a comparison of the different time periods of the study. Between-group comparison of frequencies (sick patients versus healthy subjects or paired series at different study times) will be performed by a Fisher Chi2 test or McNemar test, comparison of means by a nonparametric test or a paired t-test for paired series according to the conditions of application of the tests. The alpha risk is set at 5% for all analyses. An a posteriori power calculation will be performed retrospectively for all statistical tests. The analysis will be carried out using the SAS version V9.3 software package.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| healthy controls group | Experimental | Healthy volunteers |
|
| Alzheimer subjects group | Experimental | Group A "Alzheimer group": patients with mild to severe stages of Alzheimer's disease: subgroup A1 "Alzheimer group hospitalized at the Paul Spillmann Centre (Centre Paul Spillmann, CPS)" (CHU de Nancy, France); subgroup A2 "Alzheimer group monitored at the Resource and Research Memory Centre (Centre Mémoire de Ressources et de Recherche, CMRR)" (CHU de Nancy, France) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cognitive and psycho-behavioral effects of an artistic dimension | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Comparaison of the number of language acts in each category between AD and controls subjects | Each interaction between a subject and the psychologist is distributed into a interlocutory analysis table (Trognon and Batt, 2010 ; Batt, Trognon, Rivasseau-Jonveaux, Vernant and Jonveaux, 2014) where each utterance is noticed by its speech turn and its speech act. The second consists of a force (for example, an assertive force, as when I was eight, I loved the garden my parents owned) and a propositional content (for example, a feeling in its episodic context). Propositional content will be described according to its stimulus (for example, a kind of flower growing in the garden, a sculpture put into some place, etc.), to the interaction where it is produced and, more crucially, to the level of memory (procedural/semantics/episodics) it involves. These are the variables that will be then compared in using usual statistics between paired AD and control subjects at visit 1 and 2 | visit2 ( 10 days maximum after visit 1) |
| Measure | Description | Time Frame |
|---|---|---|
| Scores obtained in standard neuropsychological tests, in particular to assess spatio-temporal orientation (Folstein MMSE), | visit2 ( 10 days maximum after visit 1) | |
| Scores obtained with the " MemoArtZ " tool (MAZ) to evaluate the memorization of artistic elements of the garden, |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Thérèse Rivasseau Jonveaux, MD | Contact | +33(0)3 83 85 11 31 | t.jonveaux@chu-nancy.fr |
| Name | Affiliation | Role |
|---|---|---|
| Thérèse Rivasseau Jonveaux, MD | Central Hospital, Nancy, France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Nancy | Recruiting | Nancy | 54000 | France |
Not provided
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| ID | Term |
|---|---|
| D003704 | Dementia |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| visit2 ( 10 days maximum after visit 1) |
| Scores from the " General Esthetic Preference " (GEP) tool to evaluate the consistency of general esthetic appreciations, | visit2 ( 10 days maximum after visit 1) |
| obtained with the specific mood assessment scale (CSDD) for subjects in group A | visit2 ( 10 days maximum after visit1) |
| Score obtained with the specific assessment of emotional events scale (AES) for all subjects. | visit2 ( 10 days maximum after visit 1) |
| D024801 |
| Tauopathies |
| D019636 | Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |